Real-time enrollment status for this primary hyperoxaluria type 1 clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 12:05 AM UTC
| NCT Number | NCT07587021 |
| Recruiting Status | Recruiting |
| Condition | Primary Hyperoxaluria Type 1 |
| Phase | PHASE2 |
| Target Enrollment | 36 participants |
| Active Locations | 4 sites in the US |
| Sponsor | YolTech Therapeutics Co., Ltd |
| Last Updated on CT.gov | October 9, 2026 (1 week ago) |
As of October 18, 2026: Clinical trial NCT07587021 is currently recruiting participants. This phase2 study for primary hyperoxaluria type 1 is actively seeking new participants at 4 locations across the United States. The study is sponsored by YolTech Therapeutics Co., Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07587021 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07587021 was last updated 1 week ago (October 9, 2026). HelloStudys verifies this status automatically.